MedPath

Frovatriptan

Generic Name
Frovatriptan
Brand Names
Frova
Drug Type
Small Molecule
Chemical Formula
C14H17N3O
CAS Number
158747-02-5
Unique Ingredient Identifier
H82Q2D5WA7

Overview

Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head.

Indication

For the acute treatment of migraine attacks with or without aura in adults.

Associated Conditions

  • Migraine With Aura
  • Migraine Without Aura
  • Migraine;Menstrual

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Frovatriptan succinate Tablets
国药准字H20244535
化学药品
片剂
7/30/2024

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.